CNS Outcomes in ALK Fusion Positive NSCLC Patients with BM Who Received Alectinib with or without Local Therapy

被引：0
|
作者：
Miao, E. [1 ]
Lebow, E. S. [2 ]
Eichholz, J. [3 ]
Flynn, J.
Zhang, Z. [3 ,4 ]
Hubbeling, H. G.
Beal, K.
Moss, N. S. [5 ]
Yu, K. [3 ]
Yang, J. T. [3 ]
Kelly, D. W. [3 ]
Gomez, D. R. [2 ]
Rimner, A. [2 ]
Drilon, A. [5 ]
Imber, B. S. [6 ]
Pike, L. R. G. [3 ]
机构：
[1] Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, 1275 York Ave, New York, NY 10021 USA
[6] Mem Sloan Kettering Canc Ctr, Brain Metastasis Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2131
引用
收藏
页码：E59 / E60
页数：2
相关论文
共 50 条
  • [1] Alectinib shows CNS efficacy in ALK-positive NSCLC
    Gourd, Elizabeth
    LANCET ONCOLOGY, 2018, 19 (10): : E520 - E520
  • [2] Efficacy of Alectinib in Patients with ALK-Positive NSCLC and Symptomatic or Large CNS Metastases
    Lin, Jessica J.
    Jiang, Ginger Y.
    Joshipura, Nencyben
    Ackil, Jennifer
    Digumarthy, Subba R.
    Rincon, Sandra P.
    Yeap, Beow Y.
    Gainor, Justin F.
    Shaw, Alice T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (04) : 683 - 690
  • [3] Efficacy and survival outcomes of alectinib vs. crizotinib in ALK-positive NSCLC patients with CNS metastases: A retrospective study
    Liu, Qing
    Fu, Ying
    Guo, Jun
    Fu, Chunqiu
    Tang, Ning
    Zhang, Chufeng
    Han, Xiao
    Wang, Zhehai
    ONCOLOGY LETTERS, 2024, 27 (05)
  • [4] Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases—a multicenter retrospective study
    Zihua Zou
    Puyuan Xing
    Xuezhi Hao
    Yan Wang
    Xia Song
    Li Shan
    Cuiying Zhang
    Ziling Liu
    Kewei Ma
    Guilan Dong
    Junling Li
    BMC Medicine, 20
  • [5] Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases: A multicenter retrospective study
    Zou, Z.
    Xing, P.
    Hao, X.
    Wang, Y.
    Shan, L.
    Zhang, C.
    Song, X.
    Ma, K.
    Liu, Z.
    Dong, G.
    Li, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S781 - S782
  • [6] Efficacy and safety of dose-escalated alectinib in patients with metastatic ALK-positive NSCLC and CNS relapse on standard dose alectinib
    Cheung, Justin Matthew
    Kang, Jiyoon
    Yeap, Beow Y.
    Peterson, Jenn
    Do, Andrew
    Digumarthy, Subba R.
    Gainor, Justin F.
    Lin, Jessica Jiyeong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Efficacy and Safety of Dose-Escalated Alectinib in Patients with Metastatic ALK-positive NSCLC and CNS Relapse on Standard Dose Alectinib
    Cheung, Justin M.
    Kang, Jiyoon
    Yeap, Beow Y.
    Peterson, Jennifer L.
    Do, Andrew
    Gainor, Justin F.
    Digumarthy, Subba R.
    Lin, Jessica J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E31 - E31
  • [8] Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases-a multicenter retrospective study
    Zou, Zihua
    Xing, Puyuan
    Hao, Xuezhi
    Wang, Yan
    Song, Xia
    Shan, Li
    Zhang, Cuiying
    Liu, Ziling
    Ma, Kewei
    Dong, Guilan
    Li, Junling
    BMC MEDICINE, 2022, 20 (01)
  • [9] Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC
    Lin, Jessica J.
    Zhu, Viola W.
    Schoenfeld, Adam J.
    Yeap, Beow Y.
    Saxena, Ashish
    Ferris, Lorin A.
    Dagogo-Jack, Ibiayi
    Farago, Anna F.
    Taber, Angela
    Traynor, Anne
    Menon, Smitha
    Gainor, Justin F.
    Lennerz, Jochen K.
    Plodkowski, Andrew J.
    Digumarthy, Subba R.
    Ignatius, Sai-Hong
    Shaw, Alice T.
    Riely, Gregory J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : 1530 - 1538
  • [10] Impact of alectinib on survival after crizotinib failure in ALK-positive NSCLC patients
    Yoshida, T.
    Oya, Y.
    Tanaka, K.
    Junichi, S.
    Yoshitsugu, H.
    Hida, T.
    Yatabe, Y.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S619 - S619
12345